Search Our Website:
Nov 18 2019

Will Garvin, shareholder in the firm's Life Sciences industry and co-chair of the firm’s Cannabis practice group, moderated a panel called “Part I: What is the Current Federal Oversight of Cannabis-Derived Products?” at the Food and Drug Law Institute’s Legal and Practical Issues in the Evolving World of Cannabis Regulation Conference on November 18 in Washington, D.C.